The potential benefits of administering chemotherapy with radiotherapy in testicular cancer sufferers shown in study

摘要

A new study has demonstrated the potential effectiveness of administering men diagnosed with testicular cancer a single dose of chemotherapy along with radiotherapy, in an effort to both reduce the long-term adverse effects of treatment, as well as to improve treatment effectiveness. Approximately 96% of men diagnosed with testicular cancer survive, at minimum, 10 years from diagnosis; however, the more serious and advanced forms require treatment with combination chemotherapy. This form of treatment can give rise to serious long-term complications.